04 June 2021>: Original Paper
Coronavirus Disease 2019 and Kidney Transplantation in Saudi Arabia: Outcomes and Future Opportunities
Ali Alshaqaq 1ABCDEF* , Abdulnaser Al Abadi 1ACF , Abdulrahman Altheaby 2ABF , Mohammed A. Bukhari 3ABF , Basil Nasrallah 1AB , Alaa Alamoudi 4AB , Ziad Arabi 2A , Fayez Alhejaili 2B , Khalid Bin Saad 2A , Ahmed Busbaih 5B , Mohammed Abdelrahim Idris 1AB , Sumayah Askandarani 1AB , Meteb M. AlBugami 1A , Fahad E. Alotaibi 1E , Khaled Hamawi 1E , Khalid Bel’eed Akkari 1ACEDOI: 10.12659/AOT.931832
Ann Transplant 2021; 26:e931832
Table 1 Baseline patient characteristics.
Factors | Results (n=130)* |
---|---|
Male | 78 (60%) |
Female | 52 (40%) |
Age in years | 48.7±14.4 |
Body mass index (BMI) | 29.8±6.9 |
A | 36 (27.6%) |
AB | 6 (4.6%) |
B | 29 (22.3%) |
O | 59 (45.3%) |
Deceased donor | 26 (20%) |
Living | 104 (80%) |
Diabetes | 40 (30.8%) |
Glomerulonephritis | 24 (18.5%) |
Hypertension | 14 (10.8%) |
Others | 52 (40%) |
Diabetes | 58 (44.6%) |
Hypertension | 103 (79.2%) |
Ischemic heart disease | 22 (16.9%) |
Smoking | 37 (28.5%) |
Other | 65 (50%) |
Steroid | 128 (98.5%) |
Tacrolimus | 125 (96.2%) |
Mycophenolate | 121 (93.1%) |
Others | 6 (4.6%) |
≤1 year | 21 (16.2%) |
>1 year | 109 (83.8%) |
Family | 79 (60.8%) |
Community | 29 (22.3%) |
Unknown | 22 (16.9%) |
* Results are expressed as mean±standard deviation, and number (percentage). |